Dietary obesity-associated Hif1α activation in adipocytes restricts fatty acid oxidation and energy expenditure via suppression of the Sirt2-NAD+ system.

PubWeight™: 1.59‹?› | Rank: Top 4%

🔗 View Article (PMC 3278893)

Published in Genes Dev on February 01, 2012

Authors

Jaya Krishnan1, Carsten Danzer, Tatiana Simka, Josef Ukropec, Katharina Manuela Walter, Susann Kumpf, Peter Mirtschink, Barbara Ukropcova, Daniela Gasperikova, Thierry Pedrazzini, Wilhelm Krek

Author Affiliations

1: Institute of Cell Biology, ETH Zurich, Switzerland.

Articles citing this

Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell (2013) 4.85

What we talk about when we talk about fat. Cell (2014) 4.12

Fibrosis and adipose tissue dysfunction. Cell Metab (2013) 2.07

Inorganic nitrate promotes the browning of white adipose tissue through the nitrate-nitrite-nitric oxide pathway. Diabetes (2014) 1.82

Pharmacological approaches to restore mitochondrial function. Nat Rev Drug Discov (2013) 1.66

From sirtuin biology to human diseases: an update. J Biol Chem (2012) 1.60

Increased adipocyte O2 consumption triggers HIF-1α, causing inflammation and insulin resistance in obesity. Cell (2014) 1.53

Sorting out functions of sirtuins in cancer. Oncogene (2013) 1.47

Sirtuin-2 Regulates Sepsis Inflammation in ob/ob Mice. PLoS One (2016) 1.42

Adipokines: a link between obesity and cardiovascular disease. J Cardiol (2013) 1.29

Mitochondrial dysfunction in white adipose tissue. Trends Endocrinol Metab (2012) 1.22

Selective inhibition of hypoxia-inducible factor 1α ameliorates adipose tissue dysfunction. Mol Cell Biol (2012) 1.21

The sirtuin family's role in aging and age-associated pathologies. J Clin Invest (2013) 1.12

PPARα and Sirt1 mediate erythropoietin action in increasing metabolic activity and browning of white adipocytes to protect against obesity and metabolic disorders. Diabetes (2013) 1.12

Transcriptional regulation by hypoxia inducible factors. Crit Rev Biochem Mol Biol (2013) 0.94

Dietary obesity-induced Egr-1 in adipocytes facilitates energy storage via suppression of FOXC2. Sci Rep (2013) 0.92

Hypoxia-inducible factor 1α regulates a SOCS3-STAT3-adiponectin signal transduction pathway in adipocytes. J Biol Chem (2012) 0.92

Differential regulation of HIF-mediated pathways increases mitochondrial metabolism and ATP production in hypoxic osteoclasts. J Pathol (2013) 0.91

The ever-expanding role of HIF in tumour and stromal biology. Nat Cell Biol (2016) 0.89

The role of sirtuins in cardiac disease. Am J Physiol Heart Circ Physiol (2015) 0.89

HIF-driven SF3B1 induces KHK-C to enforce fructolysis and heart disease. Nature (2015) 0.89

Sirtuins in epigenetic regulation. Chem Rev (2015) 0.88

Metabolic consequences of high-fat diet are attenuated by suppression of HIF-1α. PLoS One (2012) 0.87

Gerometabolites: the pseudohypoxic aging side of cancer oncometabolites. Cell Cycle (2014) 0.86

Glucose and SIRT2 reciprocally mediate the regulation of keratin 8 by lysine acetylation. J Cell Biol (2013) 0.85

Ascent to altitude as a weight loss method: the good and bad of hypoxia inducible factor activation. Obesity (Silver Spring) (2013) 0.84

Suppression of PGC-1α Is Critical for Reprogramming Oxidative Metabolism in Renal Cell Carcinoma. Cell Rep (2015) 0.84

Cardiac-specific ablation of ARNT leads to lipotoxicity and cardiomyopathy. J Clin Invest (2014) 0.83

Targeting adipose tissue in the treatment of obesity-associated diabetes. Nat Rev Drug Discov (2016) 0.83

Fra-2/AP-1 controls adipocyte differentiation and survival by regulating PPARγ and hypoxia. Cell Death Differ (2014) 0.82

Adipocyte pseudohypoxia suppresses lipolysis and facilitates benign adipose tissue expansion. Diabetes (2014) 0.81

Sirtuins, a promising target in slowing down the ageing process. Biogerontology (2017) 0.80

The controversial world of sirtuins. Drug Discov Today Technol (2014) 0.80

The relationship between serum hypoxia-inducible factor 1α and coronary artery calcification in asymptomatic type 2 diabetic patients. Cardiovasc Diabetol (2014) 0.80

Hypoxia is associated with a lower expression of genes involved in lipogenesis in visceral adipose tissue. J Transl Med (2015) 0.79

The role of metformin and resveratrol in the prevention of hypoxia-inducible factor 1α accumulation and fibrosis in hypoxic adipose tissue. Br J Pharmacol (2016) 0.79

Prenatal ethanol exposure causes glucose intolerance with increased hepatic gluconeogenesis and histone deacetylases in adult rat offspring: reversal by tauroursodeoxycholic acid. PLoS One (2013) 0.79

Short Chain Fatty Acids Prevent High-fat-diet-induced Obesity in Mice by Regulating G Protein-coupled Receptors and Gut Microbiota. Sci Rep (2016) 0.78

Sirtuins as novel players in the pathogenesis of diabetes mellitus. World J Diabetes (2014) 0.78

Negative regulation of human growth hormone gene expression by insulin is dependent on hypoxia-inducible factor binding in primary non-tumor pituitary cells. J Biol Chem (2012) 0.78

Cell biology of fat storage. Mol Biol Cell (2016) 0.77

RAD9 deficiency enhances radiation induced bystander DNA damage and transcriptomal response. Radiat Oncol (2014) 0.77

Acetylation of TUG protein promotes the accumulation of GLUT4 glucose transporters in an insulin-responsive intracellular compartment. J Biol Chem (2015) 0.77

Sirtuins in Cancer: a Balancing Act between Genome Stability and Metabolism. Mol Cells (2015) 0.76

Adipose HIF-1α causes obesity by suppressing brown adipose tissue thermogenesis. J Mol Med (Berl) (2016) 0.76

Hypoxia-inducible factor prolyl hydroxylase 1 (PHD1) deficiency promotes hepatic steatosis and liver-specific insulin resistance in mice. Sci Rep (2016) 0.76

Differential regulation of pro- and antiapoptotic proteins in fish adipocytes during hypoxic conditions. Fish Physiol Biochem (2016) 0.76

Sirtuins Function as the Modulators in Aging-related Diseases in Common or Respectively. Chin Med J (Engl) (2015) 0.75

MicroRNAs in heart failure: Non-coding regulators of metabolic function. Biochim Biophys Acta (2016) 0.75

Does inorganic nitrate say NO to obesity by browning white adipose tissue? Adipocyte (2015) 0.75

Sirtuins in metabolism, DNA repair and cancer. J Exp Clin Cancer Res (2016) 0.75

Bile Acids, FXR, and Metabolic Effects of Bariatric Surgery. J Obes (2016) 0.75

A Systems Genetics Approach Identified GPD1L and its Molecular Mechanism for Obesity in Human Adipose Tissue. Sci Rep (2017) 0.75

Mitochondrial genomic variation associated with higher mitochondrial copy number: the Cache County Study on Memory Health and Aging. BMC Bioinformatics (2014) 0.75

Regulation of obesity and insulin resistance by hypoxia-inducible factors. Hypoxia (Auckl) (2014) 0.75

Regulation of glycolysis in brown adipocytes by HIF-1α. Sci Rep (2017) 0.75

Adipose tissue NAD(+)-homeostasis, sirtuins and poly(ADP-ribose) polymerases - important players in mitochondrial metabolism and metabolic health. Redox Biol (2017) 0.75

Expression of the SIRT2 gene and its relationship with body size traits in Qinchuan cattle (Bos taurus). Int J Mol Sci (2015) 0.75

Loss of SIRT2 leads to axonal degeneration and locomotor disability associated with redox and energy imbalance. Aging Cell (2017) 0.75

Down-regulation of single-stranded DNA-binding protein 1 expression induced by HCMV infection promotes lipid accumulation in cells. Braz J Med Biol Res (2017) 0.75

Depot-specific differences in fat mass expansion in WT and ob/ob mice. Oncotarget (2017) 0.75

Age-dependent obesity and mitochondrial dysfunction. Adipocyte (2017) 0.75

Articles cited by this

Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell (1999) 19.48

Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature (2005) 18.41

Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell (2008) 13.49

Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci U S A (1998) 9.56

The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. Mol Cell (2003) 8.34

Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Mol Cell Biol (2003) 8.12

Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr Rev (2006) 6.68

Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol Endocrinol Metab (2007) 4.94

Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue. Mol Cell Biol (2009) 3.96

Emerging role of adipose tissue hypoxia in obesity and insulin resistance. Int J Obes (Lond) (2008) 3.17

Sirtuins: Sir2-related NAD-dependent protein deacetylases. Genome Biol (2004) 3.00

The perils of portliness: causes and consequences of visceral adiposity. Diabetes (2000) 2.96

Defining high-fat-diet rat models: metabolic and molecular effects of different fat types. J Mol Endocrinol (2006) 2.81

SIRT2 deacetylates FOXO3a in response to oxidative stress and caloric restriction. Aging Cell (2007) 2.70

Cellular metabolic stress: considering how cells respond to nutrient excess. Mol Cell (2010) 2.50

Diabetic cardiomyopathy, causes and effects. Rev Endocr Metab Disord (2010) 2.47

SIRT2 regulates adipocyte differentiation through FoxO1 acetylation/deacetylation. Cell Metab (2007) 2.42

Structure of the histone deacetylase SIRT2. Nat Struct Biol (2001) 2.37

HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia. J Exp Med (2005) 2.35

Transdifferentiation properties of adipocytes in the adipose organ. Am J Physiol Endocrinol Metab (2009) 2.03

Regulation of endocytosis via the oxygen-sensing pathway. Nat Med (2009) 2.00

Depot-specific differences and insufficient subcutaneous adipose tissue angiogenesis in human obesity. Circulation (2011) 1.97

Selective expression of an aP2/Fatty Acid Binding Protein 4-Cre transgene in non-adipogenic tissues during embryonic development. Transgenic Res (2006) 1.78

Cellular hypoxia and adipose tissue dysfunction in obesity. Proc Nutr Soc (2009) 1.71

Activation of a HIF1alpha-PPARgamma axis underlies the integration of glycolytic and lipid anabolic pathways in pathologic cardiac hypertrophy. Cell Metab (2009) 1.69

Impaired adipogenesis and lipolysis in the mouse upon selective ablation of the retinoid X receptor alpha mediated by a tamoxifen-inducible chimeric Cre recombinase (Cre-ERT2) in adipocytes. Proc Natl Acad Sci U S A (2001) 1.69

Disruption of hypoxia-inducible factor 1 in adipocytes improves insulin sensitivity and decreases adiposity in high-fat diet-fed mice. Diabetes (2011) 1.56

[Not Available]. Presse Med (1947) 1.47

Brown adipose tissue-specific insulin receptor knockout shows diabetic phenotype without insulin resistance. J Clin Invest (2001) 1.39

Ectopic recombination in the central and peripheral nervous system by aP2/FABP4-Cre mice: implications for metabolism research. FEBS Lett (2010) 1.36

Visceral adiposity, insulin resistance and cancer risk. Diabetol Metab Syndr (2011) 1.26

Adipose tissue-specific inhibition of hypoxia-inducible factor 1{alpha} induces obesity and glucose intolerance by impeding energy expenditure in mice. J Biol Chem (2010) 1.20

The SIRT2 deacetylase regulates autoacetylation of p300. Mol Cell (2008) 1.11

Identification of inducible genes at the early stage of adipocyte differentiation of 3T3-L1 cells. Biochem Biophys Res Commun (1999) 1.05

Simple and accurate assessment of energy expenditure in ventilated paediatric intensive care patients. Clin Nutr (2004) 0.89

Energy metabolism of adipose tissue--physiological aspects and target in obesity treatment. Physiol Res (2004) 0.86

Increased adipose tissue expression of proinflammatory CD40, MKK4 and JNK in patients with very severe chronic obstructive pulmonary disease. Respiration (2010) 0.81

Nomograms for calculation of oxygen consumption and respiratory exchange ratio. Br Med J (1972) 0.79

Articles by these authors

Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. Nature (2003) 5.57

High sensitivity detection of plasma proteins by multiple reaction monitoring of N-glycosites. Mol Cell Proteomics (2007) 4.72

Calorie restriction increases muscle mitochondrial biogenesis in healthy humans. PLoS Med (2007) 3.92

Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL. Nat Cell Biol (2003) 3.37

Analysis of microtubule dynamic instability using a plus-end growth marker. Nat Methods (2010) 2.67

Control of nutrient-sensitive transcription programs by the unconventional prefoldin URI. Science (2003) 2.15

Role of adiponectin in human skeletal muscle bioenergetics. Cell Metab (2006) 2.09

The HRPT2 tumor suppressor gene product parafibromin associates with human PAF1 and RNA polymerase II. Mol Cell Biol (2005) 2.03

pVHL and GSK3beta are components of a primary cilium-maintenance signalling network. Nat Cell Biol (2007) 1.97

PKA phosphorylates and inactivates AMPKalpha to promote efficient lipolysis. EMBO J (2009) 1.94

Extracellular superoxide dismutase is a major determinant of nitric oxide bioavailability: in vivo and ex vivo evidence from ecSOD-deficient mice. Circ Res (2003) 1.89

Cardiac sodium channel Nav1.5 is regulated by a multiprotein complex composed of syntrophins and dystrophin. Circ Res (2006) 1.76

Induction of cardiogenesis in embryonic stem cells via downregulation of Notch1 signaling. Circ Res (2006) 1.75

pVHL and PTEN tumour suppressor proteins cooperatively suppress kidney cyst formation. EMBO J (2008) 1.72

Activation of a HIF1alpha-PPARgamma axis underlies the integration of glycolytic and lipid anabolic pathways in pathologic cardiac hypertrophy. Cell Metab (2009) 1.69

S6K1-mediated disassembly of mitochondrial URI/PP1gamma complexes activates a negative feedback program that counters S6K1 survival signaling. Mol Cell (2007) 1.66

VHL loss causes spindle misorientation and chromosome instability. Nat Cell Biol (2009) 1.65

Cancer genetics-guided discovery of serum biomarker signatures for diagnosis and prognosis of prostate cancer. Proc Natl Acad Sci U S A (2011) 1.59

Cardiac raptor ablation impairs adaptive hypertrophy, alters metabolic gene expression, and causes heart failure in mice. Circulation (2011) 1.57

Subcutaneous adipose tissue zinc-α2-glycoprotein is associated with adipose tissue and whole-body insulin sensitivity. Obesity (Silver Spring) (2014) 1.56

Overexpression of angiotensinogen in the myocardium induces downregulation of the fatty acid oxidation pathway. J Mol Cell Cardiol (2006) 1.53

Prevalence of permanent neonatal diabetes in Slovakia and successful replacement of insulin with sulfonylurea therapy in KCNJ11 and ABCC8 mutation carriers. J Clin Endocrinol Metab (2007) 1.47

Potassium supplementation reduces cardiac and renal hypertrophy independent of blood pressure in DOCA/salt mice. Hypertension (2005) 1.46

FGF-2 controls the differentiation of resident cardiac precursors into functional cardiomyocytes. J Clin Invest (2005) 1.46

miR-28-5p promotes chromosomal instability in VHL-associated cancers by inhibiting Mad2 translation. Cancer Res (2014) 1.45

Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: in vivo and in vitro studies. J Physiol (2013) 1.42

PVHL is a regulator of glucose metabolism and insulin secretion in pancreatic beta cells. Genes Dev (2008) 1.38

The A-kinase anchoring protein (AKAP)-Lbc-signaling complex mediates alpha1 adrenergic receptor-induced cardiomyocyte hypertrophy. Proc Natl Acad Sci U S A (2007) 1.34

Structural and functional consequences of mitochondrial biogenesis in human adipocytes in vitro. J Clin Endocrinol Metab (2005) 1.33

MAPK signalling in cellular metabolism: stress or wellness? EMBO Rep (2010) 1.32

Ischemic postconditioning protects remodeled myocardium via the PI3K-PKB/Akt reperfusion injury salvage kinase pathway. Cardiovasc Res (2006) 1.31

Regulation of p27 degradation and S-phase progression by Ro52 RING finger protein. Mol Cell Biol (2006) 1.31

Loss of PBRM1 expression is associated with renal cell carcinoma progression. Int J Cancer (2012) 1.27

URI is an oncogene amplified in ovarian cancer cells and is required for their survival. Cancer Cell (2011) 1.25

Angiotensin II-mediated phenotypic cardiomyocyte remodeling leads to age-dependent cardiac dysfunction and failure. Hypertension (2005) 1.25

The hypoxia-inducible microRNA cluster miR-199a∼214 targets myocardial PPARδ and impairs mitochondrial fatty acid oxidation. Cell Metab (2013) 1.24

Control of the adaptive response of the heart to stress via the Notch1 receptor pathway. J Exp Med (2008) 1.24

Sporadic clear cell renal cell carcinoma but not the papillary type is characterized by severely reduced frequency of primary cilia. Mod Pathol (2008) 1.23

Multitasking by pVHL in tumour suppression. Curr Opin Cell Biol (2007) 1.21

SIRT1: linking adaptive cellular responses to aging-associated changes in organismal physiology. Physiology (Bethesda) (2006) 1.20

Small proline-rich protein 1A is a gp130 pathway- and stress-inducible cardioprotective protein. EMBO J (2004) 1.19

URI-1 is required for DNA stability in C. elegans. Development (2006) 1.16

pVHL: a multipurpose adaptor protein. Sci Signal (2008) 1.16

Genetic variation in the Sorbs of eastern Germany in the context of broader European genetic diversity. Eur J Hum Genet (2011) 1.15

Functional role of Notch signaling in the developing and postnatal heart. J Mol Cell Cardiol (2008) 1.13

Quantitative image analysis identifies pVHL as a key regulator of microtubule dynamic instability. J Cell Biol (2010) 1.10

Remodeling lipid metabolism and improving insulin responsiveness in human primary myotubes. PLoS One (2011) 1.08

Voluntary alcohol consumption is controlled via the neuropeptide Y Y1 receptor. J Neurosci (2002) 1.08

Chronic angiotensin II stimulation in the heart produces an acquired long QT syndrome associated with IK1 potassium current downregulation. J Mol Cell Cardiol (2006) 1.08

Priming-dependent phosphorylation and regulation of the tumor suppressor pVHL by glycogen synthase kinase 3. Mol Cell Biol (2006) 1.07

Essential role of developmentally activated hypoxia-inducible factor 1alpha for cardiac morphogenesis and function. Circ Res (2008) 1.07

The VHL tumor suppressor: riding tandem with GSK3beta in primary cilium maintenance. Cell Cycle (2007) 1.07

Progenitor cell therapy for heart disease. Exp Cell Res (2009) 1.06

Myeloid differentiation factor-88/interleukin-1 signaling controls cardiac fibrosis and heart failure progression in inflammatory dilated cardiomyopathy. Circ Res (2009) 1.06

Adipogenesis and insulin sensitivity in obesity are regulated by retinoid-related orphan receptor gamma. EMBO Mol Med (2011) 1.04

p53 suppresses type II endometrial carcinomas in mice and governs endometrial tumour aggressiveness in humans. EMBO Mol Med (2012) 1.04

Small and long non-coding RNAs in cardiac homeostasis and regeneration. Biochim Biophys Acta (2012) 1.04

GLUT8 is dispensable for embryonic development but influences hippocampal neurogenesis and heart function. Mol Cell Biol (2006) 1.02

Severe insulin resistance and intrauterine growth deficiency associated with haploinsufficiency for INSR and CHN2: new insights into synergistic pathways involved in growth and metabolism. Diabetes (2009) 1.01

Connexin43-dependent mechanism modulates renin secretion and hypertension. J Clin Invest (2006) 1.00

Combined VHLH and PTEN mutation causes genital tract cystadenoma and squamous metaplasia. Mol Cell Biol (2008) 1.00

BTB proteins as henchmen of Cul3-based ubiquitin ligases. Nat Cell Biol (2003) 0.99

Cardiovascular response to beta-adrenergic blockade or activation in 23 inbred mouse strains. PLoS One (2009) 0.99

Re-expression of proteins involved in cytokinesis during cardiac hypertrophy. Exp Cell Res (2007) 0.98

The von Hippel-Lindau tumour suppressor: a multi-faceted inhibitor of tumourigenesis. Trends Mol Med (2004) 0.98

Combined mutation of Vhl and Trp53 causes renal cysts and tumours in mice. EMBO Mol Med (2013) 0.97

Deletion of the neuropeptide Y (NPY) Y1 receptor gene reveals a regulatory role of NPY on catecholamine synthesis and secretion. Proc Natl Acad Sci U S A (2006) 0.92

Comprehensive description of the N-glycoproteome of mouse pancreatic β-cells and human islets. J Proteome Res (2012) 0.92

A high-throughput-compatible 3D microtissue co-culture system for phenotypic RNAi screening applications. J Biomol Screen (2013) 0.92

KPNA2 is overexpressed in human and mouse endometrial cancers and promotes cellular proliferation. J Pathol (2014) 0.90

Stabilised beta-catenin in postnatal ventricular myocardium leads to dilated cardiomyopathy and premature death. Basic Res Cardiol (2010) 0.90

Molecular identification of 26 syntaxin genes and their assignment to the different trafficking pathways in Paramecium. Traffic (2007) 0.90

Cardiac lineage protein-1 (CLP-1) regulates cardiac remodeling via transcriptional modulation of diverse hypertrophic and fibrotic responses and angiotensin II-transforming growth factor β (TGF-β1) signaling axis. J Biol Chem (2012) 0.90

De novo mutations of GCK, HNF1A and HNF4A may be more frequent in MODY than previously assumed. Diabetologia (2013) 0.89

HIF1α deubiquitination by USP8 is essential for ciliogenesis in normoxia. EMBO Rep (2013) 0.88

Isolation of cardiovascular precursor cells from the human fetal heart. Tissue Eng Part A (2011) 0.88

Elevated intracardiac angiotensin II leads to cardiac hypertrophy and mechanical dysfunction in normotensive mice. J Renin Angiotensin Aldosterone Syst (2003) 0.88

Relationship between osteoporosis and adipose tissue leptin and osteoprotegerin in patients with chronic obstructive pulmonary disease. Bone (2011) 0.88

Mutations in HNF1A result in marked alterations of plasma glycan profile. Diabetes (2012) 0.87

Cardiac dysfunction and impaired compensatory response to pressure overload in mice deficient in stem cell antigen-1. FASEB J (2011) 0.87

Chronic neuropeptide Y infusion into the lateral ventricle induces sustained feeding and obesity in mice lacking either Npy1r or Npy5r expression. Endocrinology (2003) 0.87

The neuropeptide Y Y1 receptor regulates leptin-mediated control of energy homeostasis and reproductive functions. FASEB J (2002) 0.87

NPY and pain as seen from the histochemical side. Peptides (2007) 0.87

Relation of adipose tissue to metabolic flexibility. Diabetes Res Clin Pract (2008) 0.87

Fatty acid regulation of gene expression: a genomic explanation for the benefits of the mediterranean diet. Ann N Y Acad Sci (2002) 0.86

Identification and functional characterization of pVHL-dependent cell surface proteins in renal cell carcinoma. Neoplasia (2012) 0.86

Novel prognostic markers in the serum of patients with castration-resistant prostate cancer derived from quantitative analysis of the pten conditional knockout mouse proteome. Eur Urol (2011) 0.86

EH-myomesin splice isoform is a novel marker for dilated cardiomyopathy. Basic Res Cardiol (2010) 0.84

Relevance of nuclear and cytoplasmic von hippel lindau protein expression for renal carcinoma progression. Am J Pathol (2003) 0.84

Angiotensin II-mediated adaptive and maladaptive remodeling of cardiomyocyte excitation-contraction coupling. Circ Res (2009) 0.84

Identification of a gene expression signature common to distinct cancer pathways. Cancer Inform (2012) 0.83

Behavioural, neural and cardiovascular adaptations in mice lacking the NPY Y1 receptor. Neurosci Biobehav Rev (2004) 0.83

The neuropeptide Y Y1 receptor mediates NPY-induced inhibition of the gonadotrope axis under poor metabolic conditions. FASEB J (2003) 0.82

Overexpression of a mutant form of TGFBI/BIGH3 induces retinal degeneration in transgenic mice. Mol Vis (2008) 0.82

Increased adipose tissue expression of proinflammatory CD40, MKK4 and JNK in patients with very severe chronic obstructive pulmonary disease. Respiration (2010) 0.81